blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3600554

EP3600554 - ANTI-PATHOGEN COMPOSITION AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  13.07.2023
Database last updated on 06.07.2024
FormerRequest for examination was made
Status updated on  03.01.2020
FormerThe international publication has been made
Status updated on  06.10.2018
Most recent event   Tooltip28.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Tenfold Technologies, LLC
801 S Hwy 377
Pilot Point, TX 76258 / US
For all designated states
University Of Mississippi
100 Barr Hall
University, MS 38677 / US
[2020/06]
Inventor(s)01 / GUAN, Shaohua
13433 Morley Drive
Frisco, Texas 75035 / US
02 / RAJBANSHI, Shashi Shankar
7549 Stonebrook Parkway
Apt. 909
Frisco, Texas 75034 / US
03 / HILL, Curtis Brian
309 Turnstone Drive
Little Elm, Texas 75068 / US
04 / QIU, Shi
5 PR 3151
Apt. 10
Oxford, Mississippi 38655 / US
05 / LI, Xing Cong
14001 Woodside Cove
Oxford, Mississippi 38655 / US
 [2020/06]
Representative(s)Murray, Adrian D'Coligny, et al
Brand Murray Fuller LLP
50 Eastcastle Street
London W1W 8EA / GB
[N/P]
Former [2020/06]HGF Limited
4th Floor
Merchant Exchange
17-19 Whitworth Street West
Manchester M1 5WG / GB
Application number, filing date18777897.227.03.2018
[2020/06]
WO2018US24642
Priority number, dateUS201762477297P27.03.2017         Original published format: US 201762477297 P
US201762570919P11.10.2017         Original published format: US 201762570919 P
US201762597796P12.12.2017         Original published format: US 201762597796 P
[2020/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018183383
Date:04.10.2018
Language:EN
[2018/40]
Type: A1 Application with search report 
No.:EP3600554
Date:05.02.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 04.10.2018 takes the place of the publication of the European patent application.
[2020/06]
Search report(s)International search report - published on:US04.10.2018
(Supplementary) European search report - dispatched on:EP16.12.2020
ClassificationIPC:A61K38/15, A61P31/04, A61P31/10, C12N1/20, C12N1/21, C12P21/02
[2021/02]
CPC:
A61P31/10 (EP); A61K38/164 (US); A61K38/15 (EP);
A61P31/04 (EP); C12N1/20 (US); C12P21/02 (EP);
Y02A50/30 (EP) (-)
Former IPC [2020/06]A61P31/04, A61P31/10, C12N1/20, C12N1/21
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/06]
TitleGerman:ZUSAMMENSETZUNG GEGEN PATHOGENE UND VERFAHREN ZUR VERWENDUNG DAVON[2020/06]
English:ANTI-PATHOGEN COMPOSITION AND METHODS OF USE THEREOF[2020/06]
French:COMPOSITION ANTIPATHOGÈNES ET PROCÉDÉS D'UTILISATION DE CELLE-CI[2020/06]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase25.10.2019National basic fee paid 
25.10.2019Search fee paid 
25.10.2019Designation fee(s) paid 
25.10.2019Examination fee paid 
Examination procedure25.10.2019Examination requested  [2020/06]
29.07.2021Amendment by applicant (claims and/or description)
12.07.2023Despatch of a communication from the examining division (Time limit: M04)
22.11.2023Reply to a communication from the examining division
Fees paidRenewal fee
25.10.2019Renewal fee patent year 03
12.03.2021Renewal fee patent year 04
20.03.2022Renewal fee patent year 05
27.03.2023Renewal fee patent year 06
27.03.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]JPS62273998  (LION CORP) [X] 1-4,7-10 * the whole document * * page 6, column l; claim - * [Y] 1-12;
 [XY]JPS62273999  (LION CORP) [X] 1-4,7-10 * the whole document * [Y] 1-12;
 [XY]WO2014085576  (BAYER CROPSCIENCE LP A DELAWARE LTD PARTNERSHIP [US]) [X] 1-4,7-10 * the whole document * * paragraphs [0029] , [0076] - [0086]; example -; claim - * [Y] 1-12;
 [XY]WO2016020371  (BASF SE [DE]) [X] 1-4 * the whole document * * figure -; example -; compound - * [Y] 1-12;
 [XY]  - VATER JOACHIM ET AL, "Characterization of Novel Fusaricidins Produced byPaenibacillus polymyxa-M1 Using MALDI-TOF Mass Spectrometry", JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, ELSEVIER SCIENCE INC, US, vol. 26, no. 9, doi:10.1007/S13361-015-1130-1, ISSN 1044-0305, (20150623), pages 1548 - 1558, (20150623), XP035988587 [X] 1-4 * the whole document * * abstract * [Y] 1-12

DOI:   http://dx.doi.org/10.1007/s13361-015-1130-1
 [XY]  - BEATTY P H ET AL, "Paenibacillus polymyxa produces fusaricidin-type antifungal antibiotics active against Leptosphaeria maculans, the causative agent of blackleg disease of canola", CANADIAN JOURNAL OF MICROBIOLOGY, NRC RESEARCH PRESS, CA, (20020101), vol. 48, no. 2, doi:10.1139/W02-002, ISSN 0008-4166, pages 159 - 169, XP002993803 [X] 1-4 * the whole document * [Y] 1-12

DOI:   http://dx.doi.org/10.1139/w02-002
 [XY]  - KAJIMURA Y ET AL, "Fusaricidin A, a new depsipeptide antibiotic produced by Bacillus polymyxa KT-8.Taxonomy, fermentation, isolation, structure elucidation and biological activity", THE JOURNAL OF ANTIBIOTICS, NATURE PUBLISHING GROUP, GB, (19960201), vol. 49, no. 2, ISSN 0021-8820, pages 129 - 135, XP002993806 [X] 1-4 * the whole document * [Y] 1-12
 [T]  - SHI QIU ET AL, "Identification of fusaricidins from the antifungal microbial strain Paenibacillus sp. MS2379 using ultra-high performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry", JOURNAL OF CHROMATOGRAPHY A, AMSTERDAM, NL, (20181205), vol. 1586, doi:10.1016/j.chroma.2018.12.007, ISSN 0021-9673, pages 91 - 100, XP055756059 [T] 1-12 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.chroma.2018.12.007
 [T]  - HARON MONA H ET AL, "Quantitative determination and pharmacokinetic study of fusaricidin A in mice plasma and tissues using ultra-high performance liquid chromatography-tandem mass spectrometry", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, (2019), vol. 170, doi:10.1016/J.JPBA.2019.03.042, ISSN 0731-7085, pages 187 - 192, XP085665090 [T] 1-12 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jpba.2019.03.042
International search[XY]WO2016020371  (BASF SE [DE]) [X] 1-4, 6-7, 9/1-4, 9/6-7, 18, 20-26, 28/20-26, 36-37, 47, 49 * ; abstract; page 3, lines 15-20; page 4, lines 1-5; page 43, lines 25-30; page 57, lines 25-30; page 58, lines 20-25; page 68, lines 1-40; claims 14, 19 * [Y] 5, 8, 9/5, 9/8, 27, 28/27;
 [X]WO2014085576  (BAYER CROPSCIENCE LP A DELAWARE LTD PARTNERSHIP [US]) [X] 1, 19, 37, 48 * ; abstract; paragraphs [0031], [0050], [0063], (0083], [0096]; claims 1, 3 *;
 [A]WO2015169919  (BASF SE [DE]) [A] 38, 39/37-38, 50, 51/49-50 * ; abstract; page 19, lines 1-5 *;
 [Y]  - VATER, J et al., "Characterization of Novel Fusaricidins Produced by Paenibacillus polymyxa-M1 Using MALDI-TOF Mass Spectrometry", Journal of American Society of Mass Spectrometry, (20150623), vol. 26, no. 9, pages 1548 - 1558, XP035988587 [Y] 5, 9/5 * ; abstract, figure; page 1549, column 1, paragraph 1; page 1555, column 2, paragraph 2 *

DOI:   http://dx.doi.org/10.1007/s13361-015-1130-1
 [Y]  - BEATTY, PH et al., "Paenibacillus polymyxa produces fusaricidin-type antifungal antibiotics active against Leptosphaeria maculans, the causative agent of blackleg disease of canola", Canadian Journal of Microbiology, (20020303), vol. 48, no. 2, pages 159 - 169, XP002993803 [Y] 8, 9/8, 27, 28/27 * ; abstract; page 166, column 2, paragraph 3 *

DOI:   http://dx.doi.org/10.1139/w02-002
 [A]  - LEE, JW et al., "Mannheimia succiniciproducens Phosphotransferase System for Sucrose Utilization", Applied and Environmental Microbiology, (20100300), vol. 76, no. 5, pages 1699 - 1703, XP055108511 [A] 38, 39/37-38, 50, 51/49-50 * ; page 1703, column 1, paragraph 4 *

DOI:   http://dx.doi.org/10.1128/AEM.02468-09
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.